Maharashtra government on Saturday explained that it will procure the repurposed Ebola drug remdesivir to address significant Covid-19 clients in the point out at a value of Rs 12000 for each vial. Since the Indian producers of the drug are yet to have the promoting authorisation for the drug and its innovator Gilead is yet to start in the industry, the point out government is open to procuring it from Bangladesh.
Maharashtra has registered much more than 80,000 situations of Covid-19 and is the worst affected point out in the country.
Maharashtra well being minister Rajesh Tope explained that the point out government has determined to procure ten,000 vials of remdesivir. “It will price tag around Rs twelve crore and will be procured by means of corporate social responsibility (CSR) funds of corporates. Remdesivir has been utilised correctly from SARS and has also been advised by the Globe Well being